Business Standard

Covid-19 vax export curbs may ease in two months: Adar Poonawalla

Poonawalla said easing the export restrictions is a government of India's decision, and he will go by what the Centre feels is appropriate

Adar Poonawalla, CEO, Serum Institute
Premium

Adar Poonawalla, CEO, Serum Institute

Sohini Das Mumbai
Adar Poonawalla, chief executive officer of Serum Institute of India (SII), expects the restrictions on export of Covid vaccines to ease within two months, provided that India has created enough stockpile to weather a third wave.

Raw material supplies for the Novavax vaccine have improved compared to March, and SII plans to announce its monthly production plan in December, Poonawalla told the media on Friday.

“There was no ban on exports, but there were temporary restrictions, and rightly so. I think these will slowly ease in the next month or two, but I don’t want to venture a guess. But it will

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 17 2021 | 5:38 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com